Poland - Nowy Sącz: Antineoplastic and immunomodulating agents

Release

ID: ocds-pyfy63:2018-391943:2018-512483
Buyer: Szpital Specjalistyczny im. Jędrzeja Śniadeckiego w Nowym Sączu
Date: 2018-11-21
Language: PL
Tags: award

Release in JSON

Process

ID (OCID): ocds-pyfy63:2018-391943
Releases: 2018-09-08 (ocds-pyfy63:2018-391943:2018-391943)
2018-10-04 (ocds-pyfy63:2018-391943:2018-431706)
2018-11-21 (ocds-pyfy63:2018-391943:2018-512483)

Releases in JSON

Tender

Title: Poland - Nowy Sącz: Antineoplastic and immunomodulating agents
Award criteria: ratedCriteria
Award criteria details: The most economic tender

Award criteria for item 1:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 2:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 3:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 4:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 5:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 6:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 7:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 8:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 9:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 10:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 11:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 12:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 13:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 14:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 15:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 16:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 17:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 18:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 19:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 20:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 21:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 22:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 23:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 24:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 25:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 26:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 27:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 28:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 29:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 30:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 31:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 32:
- Cost: cena (60)
- Cost: warunki dostawy (40)
Main procurement category: goods
Procurement method: open
Procurement method details: Open procedure
Tender period: 2018-11-21 - ?
Tenderers: Urtica Sp. z o.o
PGF SA.
Asclepios SA.
Urtica Sp. z o.o.
Salus International Sp. z o. o.
Amgen Sp. z o.o.
Roche Polska Sp. z o.o.0
Roche Polska Sp. z o.o. 0
Roche Polska Sp. z o.o.
Amgen Sp. z o.o. 0
Astra Zeneca UK Limited
Janssen-Cilag Polska Sp. z o.o.
Komtur Polska Sp. z o.o.
Astellas Pharma Sp. z o.o.
Urtica Sp. z o.o. ul Krzemieniecka 120, 54-613
Servier Polska Services Sp. z o.o.
PGF SA. u
Centrala Farmaceutyczna CEFARM SA

Tender item

ID: ocds-pyfy63:2018-391943:obj:1
Classification: CPV / 33652000
Description: Leki przeciwnowotworowe

Tender item

ID: ocds-pyfy63:2018-391943:obj:2
Classification: CPV / 33652000
Description: Leki przeciwnowotworowe

Tender item

ID: ocds-pyfy63:2018-391943:obj:3
Classification: CPV / 33652000
Description: Filgasterim

Tender item

ID: ocds-pyfy63:2018-391943:obj:4
Classification: CPV / 33652000
Description: Leki przeciwnowotworowe

Tender item

ID: ocds-pyfy63:2018-391943:obj:5
Classification: CPV / 33652000
Description: Bendamustine

Tender item

ID: ocds-pyfy63:2018-391943:obj:6
Classification: CPV / 33652000
Description: Leki przeciwnowotworowe

Tender item

ID: ocds-pyfy63:2018-391943:obj:7
Classification: CPV / 33652000
Description: Leki przeciwnowotworowe

Tender item

ID: ocds-pyfy63:2018-391943:obj:8
Classification: CPV / 33652000
Description: Leki przeciwnowotworowe

Tender item

ID: ocds-pyfy63:2018-391943:obj:9
Classification: CPV / 33652000
Description: Leki przeciwnowotworowe

Tender item

ID: ocds-pyfy63:2018-391943:obj:10
Classification: CPV / 33652000
Description: Rituximab

Tender item

ID: ocds-pyfy63:2018-391943:obj:11
Classification: CPV / 33652000
Description: Pertuzumab i Trastuzumab

Tender item

ID: ocds-pyfy63:2018-391943:obj:12
Classification: CPV / 33652000
Description: Trastuzumab

Tender item

ID: ocds-pyfy63:2018-391943:obj:13
Classification: CPV / 33652000
Description: Olaparyb

Tender item

ID: ocds-pyfy63:2018-391943:obj:14
Classification: CPV / 33652000
Description: Doxorubicinum lizosomalna pegylowana

Tender item

ID: ocds-pyfy63:2018-391943:obj:15
Classification: CPV / 33652000
Description: Vinorelbinum

Tender item

ID: ocds-pyfy63:2018-391943:obj:16
Classification: CPV / 33652000
Description: Bortezomib

Tender item

ID: ocds-pyfy63:2018-391943:obj:17
Classification: CPV / 33652000
Description: Anagrelid

Tender item

ID: ocds-pyfy63:2018-391943:obj:18
Classification: CPV / 33652000
Description: Lapatinib

Tender item

ID: ocds-pyfy63:2018-391943:obj:19
Classification: CPV / 33652000
Description: Cytarabina liposomalna

Tender item

ID: ocds-pyfy63:2018-391943:obj:20
Classification: CPV / 33652000
Description: Leki przeciwnowotworowe

Tender item

ID: ocds-pyfy63:2018-391943:obj:21
Classification: CPV / 33652000
Description: Octan abirateronu

Tender item

ID: ocds-pyfy63:2018-391943:obj:22
Classification: CPV / 33652000
Description: Gefitinib

Tender item

ID: ocds-pyfy63:2018-391943:obj:23
Classification: CPV / 33652000
Description: Imatinib

Tender item

ID: ocds-pyfy63:2018-391943:obj:24
Classification: CPV / 33652000
Description: Afatynib

Tender item

ID: ocds-pyfy63:2018-391943:obj:25
Classification: CPV / 33652000
Description: Enzalutamid

Tender item

ID: ocds-pyfy63:2018-391943:obj:26
Classification: CPV / 33652000
Description: Ozymertynib

Tender item

ID: ocds-pyfy63:2018-391943:obj:27
Classification: CPV / 33652000
Description: Ruksolitynib

Tender item

ID: ocds-pyfy63:2018-391943:obj:28
Classification: CPV / 33652000
Description: Ibrutynib

Tender item

ID: ocds-pyfy63:2018-391943:obj:29
Classification: CPV / 33652000
Description: Eltrombopag

Tender item

ID: ocds-pyfy63:2018-391943:obj:30
Classification: CPV / 33652000
Description: Piksantron

Tender item

ID: ocds-pyfy63:2018-391943:obj:31
Classification: CPV / 33652000
Description: Dasatynib

Tender item

ID: ocds-pyfy63:2018-391943:obj:32
Classification: CPV / 33652000
Description: Brentuksymab

Award

ID: ocds-pyfy63:2018-391943:award:0
Title: Leki przeciwnowotworowe
Date: 2018-11-15
Status: active
Suppliers: Urtica Sp. z o.o
PGF SA.

Award

ID: ocds-pyfy63:2018-391943:award:1
Title: Leki przeciwnowotworowe
Date: 2018-11-07
Status: active
Suppliers: Asclepios SA.

Award

ID: ocds-pyfy63:2018-391943:award:2
Title: Filgasterim
Date: 2018-11-15
Status: active
Suppliers: Urtica Sp. z o.o.
PGF SA.

Award

ID: ocds-pyfy63:2018-391943:award:3
Title: Leki przeciwnowotworowe
Date: 2018-11-07
Status: active
Suppliers: Asclepios SA.

Award

ID: ocds-pyfy63:2018-391943:award:4
Title: Bendamustine
Date: 2018-11-15
Status: active
Suppliers: Urtica Sp. z o.o.
PGF SA.

Award

ID: ocds-pyfy63:2018-391943:award:5
Title: Leki przeciwnowotworowe
Date: 2018-11-07
Status: active
Suppliers: Asclepios SA.

Award

ID: ocds-pyfy63:2018-391943:award:6
Title: Leki przeciwnowotworowe
Date: 2018-11-07
Status: active
Suppliers: Salus International Sp. z o. o.

Award

ID: ocds-pyfy63:2018-391943:award:7
Title: Leki przeciwnowotworowe
Date: 2018-11-07
Status: active
Suppliers: Amgen Sp. z o.o.

Award

ID: ocds-pyfy63:2018-391943:award:8
Title: Leki przeciwnowotworowe
Date: 2018-11-07
Status: active
Suppliers: Roche Polska Sp. z o.o.0

Award

ID: ocds-pyfy63:2018-391943:award:9
Title: Rituximab
Date: 2018-11-07
Status: active
Suppliers: Roche Polska Sp. z o.o. 0

Award

ID: ocds-pyfy63:2018-391943:award:10
Title: Pertuzumab i Trastuzumab
Date: 2018-11-07
Status: active
Suppliers: Roche Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2018-391943:award:11
Title: Trastuzumab
Date: 2018-11-07
Status: active
Suppliers: Amgen Sp. z o.o. 0

Award

ID: ocds-pyfy63:2018-391943:award:12
Title: Olaparyb
Date: 2018-11-07
Status: active
Suppliers: Astra Zeneca UK Limited

Award

ID: ocds-pyfy63:2018-391943:award:13
Title: Doxorubicinum lizosomalna pegylowana
Date: 2018-11-07
Status: active
Suppliers: Janssen-Cilag Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2018-391943:award:14
Title: Vinorelbinum
Date: 2018-11-15
Status: active
Suppliers: Urtica Sp. z o.o.
PGF SA.

Award

ID: ocds-pyfy63:2018-391943:award:15
Title: Bortezomib
Date: 2018-11-15
Status: active
Suppliers: Urtica Sp. z o.o.
PGF SA.

Award

ID: ocds-pyfy63:2018-391943:award:16
Title: Anagrelid
Date: 2018-11-07
Status: active
Suppliers: Salus International Sp. z o. o.

Award

ID: ocds-pyfy63:2018-391943:award:17
Title: Lapatinib
Date: 2018-11-15
Status: active
Suppliers: Urtica Sp. z o.o.
PGF SA.

Award

ID: ocds-pyfy63:2018-391943:award:18
Title: Cytarabina liposomalna
Status: unsuccessful

Award

ID: ocds-pyfy63:2018-391943:award:19
Title: Leki przeciwnowotworowe
Date: 2018-11-07
Status: active
Suppliers: Komtur Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2018-391943:award:20
Title: Octan abirateronu
Date: 2018-11-07
Status: active
Suppliers: Janssen-Cilag Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2018-391943:award:21
Title: Gefitinib
Date: 2018-11-07
Status: active
Suppliers: Astra Zeneca UK Limited

Award

ID: ocds-pyfy63:2018-391943:award:22
Title: Imatinib
Date: 2018-11-15
Status: active
Suppliers: Urtica Sp. z o.o.
PGF SA.

Award

ID: ocds-pyfy63:2018-391943:award:23
Title: Afatynib
Date: 2018-11-15
Status: active
Suppliers: Urtica Sp. z o.o.
PGF SA.

Award

ID: ocds-pyfy63:2018-391943:award:24
Title: Enzalutamid
Date: 2018-11-07
Status: active
Suppliers: Astellas Pharma Sp. z o.o.

Award

ID: ocds-pyfy63:2018-391943:award:25
Title: Ozymertynib
Date: 2018-11-07
Status: active
Suppliers: Astra Zeneca UK Limited

Award

ID: ocds-pyfy63:2018-391943:award:26
Title: Ruksolitynib
Date: 2018-11-15
Status: active
Suppliers: Urtica Sp. z o.o. ul Krzemieniecka 120, 54-613
PGF SA.

Award

ID: ocds-pyfy63:2018-391943:award:27
Title: Ibrutynib
Date: 2018-11-07
Status: active
Suppliers: Janssen-Cilag Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2018-391943:award:28
Title: Eltrombopag
Date: 2018-11-15
Status: active
Suppliers: Urtica Sp. z o.o.
PGF SA.

Award

ID: ocds-pyfy63:2018-391943:award:29
Title: Piksantron
Date: 2018-11-07
Status: active
Suppliers: Servier Polska Services Sp. z o.o.

Award

ID: ocds-pyfy63:2018-391943:award:30
Title: Dasatynib
Date: 2018-11-15
Status: active
Suppliers: Urtica Sp. z o.o.
PGF SA. u

Award

ID: ocds-pyfy63:2018-391943:award:31
Title: Brentuksymab
Date: 2018-11-15
Status: active
Suppliers: Centrala Farmaceutyczna CEFARM SA

Parties

Roles: buyer
Organization name: Szpital Specjalistyczny im. Jędrzeja Śniadeckiego w Nowym Sączu
Street address: ul. Młyńska 10
Locality: Nowy Sącz
Postal code: 33-300
Country: PL
Contact name: Zespół ds. zamówień publicznych
E-mail: zamowieniapubliczne@szpitalnowysacz.pl
Phone: +48 184436635
Fax: +48 184436635
Website: www.szpitalnowysacz.pl